LC-MS/MS-Based Site-Specific N-Glycosylation Analysis of VEGFR-IgG Fusion Protein for Sialylation Assessment Across IEF Fractions
Molecules · 2024
DOI: 10.3390/molecules29225393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Kwang Hoe Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: CellKey Inc., Cheongju 28160, Republic of Korea. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Immunoglobulin G, Recombinant Fusion Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Chungbuk Bioindustry-University Cooperation Institute.
Abstract (Originalsprache)
The glycosylation profile of therapeutic proteins significantly influences their efficacy, stability, and immunogenicity. Sialylation is crucial for the biological activity and pharmacokinetics of fusion proteins used in treating angiogenic disorders, making sialic acid levels a critical quality attribute in the development and production of biologics. In this study, we employed a mass spectrometry-based approach to assess sialylation levels through site-specific N-glycosylation analysis. To validate the method’s effectiveness, IEF fractions (acidic, main, and basic) obtained from the production media of the VEGFR-IgG fusion protein and anticipated to exhibit varying sialylation levels were analyzed. Our analytical method successfully evaluated the sialylation levels of each domain—IgG, VEGFR-1, and VEGFR-2—within the Fc-fusion protein. The results confirm that the overall sialylation level of the Fc-fusion protein correlated with the levels observed across the IEF fractions. This finding highlights the value of LC-MS/MS-based sialylation monitoring as a crucial tool for biosimilar development and quality control, particularly in optimizing target protein production. Additionally, glycopeptide-based LC-MS analysis enables site-specific sialylation evaluation, ensuring consistent profiles for robust quality assurance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CellKey Inc., Cheongju 28160, Republic of Korea.
- Digital Omics Research Center, Korea Basic Science Institute, Ochang 28119, Republic of Korea.
- Department of Bio-Analytical Science, University of Science and Technology, Daejeon 34113, Republic of Korea.
- Department of Biotechnology, Graduate School, Korea University, Seoul 02841, Republic of Korea.
- Department of Biomedical Science, Cheongju University, Cheongju 28160, Republic of Korea.
ORCID-Profile: Kwang Hoe Kim, Ju Yeon Lee, Yeong Hee Ahn
Förderung
- Ministry of Education
- Chungbuk Bioindustry-University Cooperation Institute
Zitieren
APA
Kim, K. H., Ji, E. S., Lee, J. Y., Song, J. H., & Ahn, Y. H. (2024). LC-MS/MS-Based Site-Specific N-Glycosylation Analysis of VEGFR-IgG Fusion Protein for Sialylation Assessment Across IEF Fractions. Molecules. https://doi.org/10.3390/molecules29225393
Vancouver
Kim KH, Ji ES, Lee JY, Song JH, Ahn YH. LC-MS/MS-Based Site-Specific N-Glycosylation Analysis of VEGFR-IgG Fusion Protein for Sialylation Assessment Across IEF Fractions. Molecules. 2024. doi:10.3390/molecules29225393
BibTeX
@article{Kim2024,
author = {Kim, Kwang Hoe and Ji, Eun Sun and Lee, Ju Yeon and Song, Ju Hwan and Ahn, Yeong Hee},
title = {LC-MS/MS-Based Site-Specific N-Glycosylation Analysis of VEGFR-IgG Fusion Protein for Sialylation Assessment Across IEF Fractions},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29225393}
}
EUVIMED